arrow
Á

Álvaro López-Janeiro

university of navarra
H指数:14
被引数:1,445

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated Single-Cell and Spatial Multi-Omics of Clonal Precursors and Immune Niches in Germinal Center Lymphomas

整合克隆前体和免疫微环境的生发中心淋巴瘤的单细胞与空间多组学分析

Cancers
IF4.4
2026-04-030
OAAI
Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients

PD-1、LAG-3和TIM-3在肿瘤内CD8 T细胞上的表达与接受阿替利珠单抗治疗的晚期尿路上皮癌患者治疗反应的相关性:一项真实世界证据生物标志物研究

2025-08-080
OAAI
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

作者更正: 溶瘤DNX-2401病毒疗法联合pembrolizumab治疗复发性胶质母细胞瘤: 1/2期试验

2025-07-210
OA
MONEO: Phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC)
2023-06-011
OA
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
2023-05-15113
OAAI
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression
2023-02-0617
OAAI
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19
CHEST
IF8.6
2022-11-0131
OAAI